Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. [electronic resource]
Producer: 20090617Description: 1731-8 p. digitalISSN:- 1878-5875
- Adenocarcinoma -- enzymology
- Apoptosis -- drug effects
- Caspase 3 -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Down-Regulation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Humans
- MAP Kinase Signaling System -- drug effects
- Pancreatic Neoplasms -- enzymology
- Plasminogen Activator Inhibitor 2 -- metabolism
- RNA, Small Interfering -- metabolism
- Receptors, Urokinase Plasminogen Activator -- metabolism
- Urokinase-Type Plasminogen Activator -- metabolism
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.